Institutional investors purchased a net $3.5 million shares of IMMU during the quarter ended September 2015, and now own 47.23% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
J.P. TURNER & CO. CAPITAL MANAGE... Bought 4.3 Million shares of Immunomedics Inc
ORBIMED ADVISORS LLC Bought 3.3 Million shares of Immunomedics Inc
BALYASNY ASSET MANAGEMENT LP Bought 2.0 Million shares of Immunomedics Inc